Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-α gene expression in monocytic cells via NF-κB involving PKC, PI3-K and tyrosine kinases

Journal of Molecular Biology

Volumn 298, Issue 5, 2000, Pages 765-778

  D'Addario, Mario ^a   Ahmad, Ali ^a   Morgan, Andrew ^b   Menezes, José ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

EBV; gp350; Monocytes; Signaling; TNF

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; CYTOKINE; GLYCOPROTEIN GP 350; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; LEUKOCYTE ENZYME; MESSENGER RNA; MONOCLONAL ANTIBODY OKB 7; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HERPES VIRUS; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION;

EID: 0034685620     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.3717     Document Type: Article

References (59)

1. Epstein-Barr virus associated lymphoproliferative disorders in immunocompromised individuals
2. Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines
3. The complete sequence of the full-length cDNA for glyceraldehyde-3-phosphate dehydrogenase: Evidence for multiple mRNA species
4. Pep34, synthetic peptide whose sequence corresponds to the intracytoplasmic domain of the Epstein-Barr virus receptor (CR2/CD21), regulates human B lymphocyte proliferation triggered through CR2
5. Herpesviruses-Immune escape artists
6. Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its 3 intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein, and the nuclear p120 ribonucleoprotein
7. The biology of cachectin/TNF - A primary mediator of host response
8. Epstein-Barr virus/C3d receptor (CR2,CD21) activated by its extracellular ligands regulates pp105 phosphorylation through 2 distinct pathways
9. Signaling through the Epstein-Barr virus/C3d receptor (CR2, CD21) in human B-lymphocyte: Activation of phosphatidylinositol 3-kinase through a CD19 independent pathway
10. The CD19/CD21 signal transduction complex of human B-lymphocytes includes the target of anti-proliferative antibody-1 and Leu13 molecules
11. Signal transduction by the B-cell antigen receptor and co-receptor
12. Single step method of RNA isolation by acid guanidium thiocyanatephenol-chloroform extraction
13. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion
14. Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-Fos gene transcription
15. Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1 infected promonocytic cells
16. Induction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 (HIV-1) in human monocyte/macrophages: Requirement of gamma interferon for IL-12 secretion
17. The CD19/CR2/TAPA-1 complex of B lymphocytes: Linking natural to acquired immunity
18. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CD21
19. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21)
20. Human herpes virus-6 induced interleukin-1β and tumor necrosis factor-a but not interleukin-6 in peripheral blood mononuclear cell cultures
21. gp140, the C3d receptor of human B-lymphocytes, is also the Epstein-Barr virus receptor
22. A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphorylation of transformed CR2 positive human lymphocytes and of normal resting B-lymphocytes
23. Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus
24. Coordinate viral induction of tumor necrosis factor-α and interferon-β in human B cells and monocytes
25. Human tumor necrosis factor-α gene regulation by virus and lipopolysaccharide
26. Epstein-Barr virus inhibits tumor necrosis factor-α transcription in monocytic cells
27. Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses: Differential induction of interleukin-6 and tumor necrosis factor alpha
28. Modulatory effects of Epstein-Barr, herpes simplex and human herpes-6 viral infections and co-infections on cytokine synthesis: A comparative study
29. Characterization of a 70-kDa, EBV gp350/220 binding protein on HSB-2 T cells
30. C3d receptors are expressed on human monocytes after in vitro cultivation
31. Infection of human endothelial cells with Epstein-Barr virus
32. Activation of human thymocytes after infection by Epstein-Barr virus
33. Model of Epstein-Barr virus infection of human thymocytes: Expression of viral genome and impact on cellular receptor expression in the T lymphoblastic cell line, HPB-ALL
34. Epstein-Barr virus and its replication
35. Human immunodeficiency virus 1 envelope proteins induce interleukin-1, tumor necrosis factor-α and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain
36. Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papilloma virus vector expression system
37. Herpesvirus-lymphoid cell interactions: Comparative studies on the biology of herpes simplex virus induced Fc receptors in B, T, and 'null' lymphoid cell lines
38. Epstein-Barr virus interactions with human lymphocyte cell populations, virus adsorption, kinetic of expression of EBV associated nuclear antigen and lymphocyte transformation
39. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor
40. Comparison of the yield of infectious virus from clones of human simian lymphoblastoid lines transformed by Epstein-Barr virus
41. Interleukin-10
42. Recent progress in EBV vaccine development
43. Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein 340 protects cottontop tamarins against EB virus induced malignant lymphomas
44. Human lymphotoxin and tumor necrosis factor genes, homology and chromosomal localization
45. Identification and characterization of the Epstein-Barr virus receptor on human B-lymphocytes and its relationship to the C3d complement receptor (CR2)
46. Epstein-Barr virus persistence and virus associated tumors
47. Epstein-Barr virus DNA sequences in precursor monocytemacrophage cell lines established from the bone marrow of children with maturation defects of hematopoeisis
48. Recombinant gp120 specifically enhances tumor necrosis factor-α production and Ig secretion in B-lymphocytes from HIV infected individuals but not from sero-negative donors
49. Induction of monocytic differentiation and NF-κB like activities by human immunodeficiency virus-1 infection of myelomonoblastic cells
50. + (cytotoxic/suppressor) T lymphocytes
51. One step ahead of the game: Viral immunomodulatory molecules
52. Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-κB production
53. Epstein-Barr virus gp350/220 binding to the lymphocyte C3d receptor mediates adsorption, capping, and endocytosis
54. Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220
55. Human immunodeficiency virus gp120 inhibits interleukin-12, secretion by human monocytes: An indirect interleukin-10 mediated effect
56. 3d receptors during human B cell differentiation: Immunofluorescence analysis with the HB-5 monoclonal antibody
57. Triggering of complement receptor CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NF-κB (p50/p65) in human monocytes and enhances viral replication in HIV-infected monocytic cells
58. Epstein-Barr virus induces proliferation of immature human thymocytes in an IL-2 mediated response
59. Tumor necrosis factor: New insights into the molecular mechanisms of its multiple actions